-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda Seeks FDA Approval for Oveporexton Following Positive Phase 3 Results in Narcolepsy Type 1

Reuters·07/14/2025 07:00:23

Please log in to view news